APA (7th ed.) Citation

Blom, T., Meinsma, R., di Summa, F., van den Akker, E., van Kuilenburg, A. B. P., Hansen, M., & Tytgat, G. A. M. (2021). Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes. EJNMMI Research, 11(1), 1. https://doi.org/10.1186/s13550-021-00823-5

Chicago Style (17th ed.) Citation

Blom, Thomas, Rutger Meinsma, Franca di Summa, Emile van den Akker, André B. P. van Kuilenburg, Marten Hansen, and Godelieve A. M. Tytgat. "Thrombocytopenia After Meta-iodobenzylguanidine (MIBG) Therapy in Neuroblastoma Patients May Be Caused by Selective MIBG Uptake via the Serotonin Transporter Located on Megakaryocytes." EJNMMI Research 11, no. 1 (2021): 1. https://doi.org/10.1186/s13550-021-00823-5.

MLA (9th ed.) Citation

Blom, Thomas, et al. "Thrombocytopenia After Meta-iodobenzylguanidine (MIBG) Therapy in Neuroblastoma Patients May Be Caused by Selective MIBG Uptake via the Serotonin Transporter Located on Megakaryocytes." EJNMMI Research, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1186/s13550-021-00823-5.